1,081 results on '"Warner, Andrew"'
Search Results
202. 87: Is Prostate Brachytherapy A Dying Art? Evidence of Increasing Utilization in Ontario
203. 151: What is the Optimal Treatment of Malignant Triton Tumours in Adults? A Systematic Review of the Literature
204. 53: Utility of Post-Treatment Pet in Hpv Associated Oropharyngeal Cancer: A Systematic Review and Meta-Analysis
205. Postural Instability and Seasickness in a Motion-Based Shooting Simulation
206. 51: A Phase Iii Randomized Trial of Palliative Radiation for Advanced Central Lung Tumours with Intentional Avoidance of the Esophagus (Proactive)
207. 132: Is There A Role for Hypofractionated Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis
208. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
209. 8: Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-Comet Randomized Trial
210. Abstract 770: Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: a first-in-human pilot study
211. Preservation of Swallowing in Resected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): Study Protocol for a Randomized Phase II Trial
212. Automatic cancer detection on digital histopathology images of mid-gland radical prostatectomy specimens
213. Is there a role for hypofractionated thoracic radiotherapy in limited-stage small cell lung cancer? a propensity score matched analysis.
214. Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study.
215. Is prostate brachytherapy a dying art? Evidence of increasing utilization in Ontario, Canada.
216. Quality of Written Feedback given to Medical Students after Introduction of Real-Time Audio Monitoring of Clinical Encounters
217. MP70-02 DOES SALVAGE WHOLE GLAND CYROABLATION THERAPY CONFER SURVIVAL ADVANTAGE TO PATIENTS WHO FAILED PRIMARY RADIOTHERAPY FOR PROSTATE CANCER?
218. Is lung stereotactic ablative radiotherapy safe after pneumonectomy?—a systematic review
219. Points to consider regarding the SABR-COMET trial – Authors' reply
220. Results of surgical resection of carotid body tumors: A twenty-year experience
221. QUALITY OF LIFE OUTCOMES AFTER STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) VERSUS STANDARD OF CARE PALLIATIVE TREATMENTS: A SECONDARY ANALYSIS OF THE SABR-COMET RANDOMIZED TRIAL
222. Additional file 1: of Stereotactic ablative radiotherapy for the comprehensive treatment of 4â 10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
223. Additional file 3: of Stereotactic ablative radiotherapy for the comprehensive treatment of 4â 10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
224. Additional file 2: of Stereotactic ablative radiotherapy for the comprehensive treatment of 4â 10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
225. Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12–13 region of fibrillin-1
226. Macroeconomic Effects of Terms-of-Trade Shocks: The Case of Oil-Exporting Countries
227. Gay marriage
228. Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non–small-cell Lung Cancer (NCT02788461)
229. SUNSET: Stereotactic Radiation for Ultracentral Non–Small-Cell Lung Cancer—A Safety and Efficacy Trial
230. Mexico's investment collapse: debt or oil?
231. The secret behind American export success
232. Colonic inflammatory bowel disease: medical therapies for colonic Crohn's disease and ulcerative colitis
233. The case against Saddam Hussein - the case for world order.
234. Risk of early surgery for Crohn's disease: implications for early treatment strategies
235. The impact of multilevel security on database buffer management
236. Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
237. Additional file 3: of A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma
238. Additional file 3: of Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based?
239. Additional file 1: of Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based?
240. Additional file 2: of Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based?
241. Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial
242. Proactive versus reactive feeding tube (FT) placement in head and neck cancer patients (HNC pts) receiving chemoradiation (CRT).
243. 19 Stereotactic Body Radiotherapy for Large Primary Large Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)
244. 92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET
245. 97 Lung Stereotactic Ablative Radiotherapy Following Pneumonectomy: A Systematic Review of Clinical and Toxicity Outcomes
246. 96 Does Free Nicotine Replacement Therapy Lead to Improved Smoking Cessation Rates in Cancer Patients? Results of a Pilot Study
247. 91 Quality of Life Outcomes After Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial
248. 133 Does “5+5” Equal Better Radiation Treatment Plans in Head and Neck Cancers?
249. 88 Radiotherapy Versus Trans-Oral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Results of a Randomized Trial
250. 147 Are Female Radiation Oncologists Still Underrepresented in the Published Literature? An Analysis of Authorship Trends Over the Past Decade
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.